Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
Change in Working Capital history
Currency unavailable · from the cash flow
No Change in Working Capital data reported for this period type.
Change in Working Capital vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $90.89M USD | +54.3% | — | 39.1% | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | $13.49M USD | -58.1% | — | 182.4% |
| LTM Mar 2026 | $10.92M USD | +78.7% | -42.2% | — | |
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | $4.71M USD | +342.2% | +15.4% | — |
| LTM Mar 2026 | $2.98M USD | -83.4% | — | 35.6% | |
| LTM Sep 2026 | $2.19M USD | -130.6% | +2.5% | 2.4% | |
| LTM Jun 2026 | $705K USD | +101.4% | — | 0.3% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +54.3% | +2.5% | 35.6% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.